Atorvastatin calcium makes up 2.8 percent of outpatient prescription medication claims, according to a Dec. 30 report from Definitive Healthcare.
Category: Supply Chain
Top supply leaders' plans for 2023 and 7 more supply chain updates
Here are eight supply chain updates for ASC leaders reported by Becker’s since Dec. 20:
Philips' new apnea masks have low risk of harm, 5 labs find
The reworked CPAP and BiPAP machines from Philips Respironics were found to be “unlikely to result in an appreciable harm to health in patients,” Philips said Dec. 21.
Advanced Biologics to pay over $12M for allegedly violating False Claims Act
Valencia, Calif.-based Advanced Biologics has agreed to pay over $12 million for allegedly violating the False Claims Act by misleading federal programs regarding radio-frequency emissions generated by cochlear implants, according to a Dec. 20 report f…
A Netflix-esque antibiotic service and 12 more supply chain updates
From a purchase cap on pediatric medications to new flu treatment protocol, here are 13 supply chain updates for ASC leaders to know reported by Becker’s since Dec. 13:
Supply chain priorities for 2023: 4 leaders weigh in
After more than two years of disruptions and high demand, supply chain leaders are taking the lessons learned in the COVID-19 pandemic to strengthen their supply chain in hopes of preventing issues from resurfacing.
'Make your priorities align with their priorities': NYU Langone's VP of supply chain on measuring success
People are the focus of supply chain decisions for Jacquelyn Marcus, vice president for supply chain management at NYU Langone Health in New York City.
How MD Anderson built a strong blood supply
To ensure Houston-based MD Anderson, the nation’s largest transfusing hospital, has enough blood, its donor operations team pivoted to solutions such as more double red cell donations and outreach.
How to tackle shortages, competition and 10 more supply chain updates
Here are 11 supply chain updates for ASC leaders to know reported by Becker’s since Dec. 6:
Medical devicemaker settles for $14.5M in country mix-up case
Medical device company Coloplast agreed to settle a U.S. lawsuit for $14.5 million after it self-reported a failure to offer contractual discounts and documented incorrect countries of origin for some products.
